Government Shutdown
- Funding for much of the federal government lapsed on October 1 with the start of a new fiscal year. Government funding is supposed to be enacted through passage of 12 annual appropriations bills or a stopgap measure known as a continuing resolution (CR) that will keep funding levels as-is from the previous year for a temporary amount of time. No FY26 appropriations bills have yet been agreed to by both chambers.
- The House passed a 鈥渃lean鈥 (free of any policy changes) CR that would fund the government through November 21, 2025. That bill has failed three attempts to reach the 60-vote threshold needed for passage in the Senate, with a majority of Senate Democrats opposing.
- Senate Democrats offered their own CR that would have rolled back Medicaid cuts, permanently extended enhanced Affordable Care Act tax credits, and limited the capabilities of the Administration to rescind funding already appropriated by Congress. This bill also failed when brought to the floor for a vote.
- Republican leaders today made it clear that they have no plans to cede to the Democrats鈥 demands and said that Republicans will not engage in policy changes until Democrats first agree to vote to reopen the government.
- Unlike in past shutdowns, President Trump and Office of Management and Budget Director Russ Vought have threatened to enact mass layoffs of federal workers unless Democrats vote in favor of reopening the government. We are also seeing rollbacks of federal funding for projects primarily in blue states.
- Each federal agency will publish contingency guidance for government workers, detailing essential from nonessential work. As of today, even senior leadership in some federal agencies have been furloughed.
- Glimmer of hope? Three Senate Democrats have joined Republicans in voting to pass the CR and reopen the government 鈥 however, that鈥檚 still far from the number of Democrats needed. With that said, there have been bipartisan discussions among Senate R鈥檚 and D鈥檚 on a path forward for the ACA subsidies, leading to chatter that the shutdown may not last as long as the roughly 40-day shutdown in 2018. More to come.
The House and Senate are both in session next week, despite the government being shutdown.
Please reach out to the authors or your 麻豆传媒 relationship partner if you are facing any issues, or if you have any questions, with the ongoing changes by the Trump administration.
Author(s)
Related Insights
June 2, 2026
Health Care Law Today
AI, Virtual Care, and EHR Optimization: What Hospitals Should Watch as AHA and West Health Launch National Accelerator
The American Hospital Association (AHA) and the West Health Institute recently announced the launch of the West Health Accelerator (Accelerator) at AHA鈥檚 Health Research & Educational Trust (HRET), a three-year national initiative designed to help hospitals and health systems operationalize and scale proven technologies across care environments. The initiative is supported by a $12 million commitment from West Health Institute and will focus on three priority areas: electronic health record (EHR) optimization, virtual care, and artificial intelligence (AI) utilization and integration.
June 1, 2026
Health Care Law Today
Clinical Trial Transparency Enforcement: A Practical Guide for Sponsors and Research Sites After FDA鈥檚 April 2026 Reminders
On April 13, 2026, the U.S. Food & Drug Administration (FDA) publicly disclosed that it had sent targeted reminder messages on March 30, 2026, to more than 2,200 sponsors and researchers concerning over 3,000 registered clinical trials that appear to lack required results postings on ClinicalTrials.gov.
June 1, 2026
Health Care Law Today
FDA鈥檚 One-Day Inspectional Assessments Pilot: A Risk-Based Shift in Oversight 鈥 What Regulated Entities Need to Know and How to Comply
On May 6, 2026, the U.S. Food & Drug Administration (FDA) announced the launch of a pilot program for one-day inspectional assessments 鈥 a new, streamlined screening tool designed to make the agency鈥檚 inspectional resources more targeted and efficient. Then former FDA Commissioner Marty Makary, M.D., M.P.H., described the initiative as a way to 鈥渟trengthen our inspectional approach by focusing our time and resources where they are most needed,鈥 while minimizing operational disruption for lower-risk establishments. There is no indication from FDA that this initiative will change after Commissioner Makary鈥檚 recent resignation.